Oncology - Lung Cancer General Flashcards

(30 cards)

1
Q

How common is lung Ca?

A

MOST COMMON cancer

LEADING CAUSE of cancer death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe clinical features of Adenocarcinoma

A
  • 85% of NSCLC
  • Typically peripheral
  • assoc with SMOKING
    BUT
    most common type of lung Ca in NONSMOKERS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Histo features of adenocarcinoma

A

Histo: signet ring, or clear cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe clinical features of Squamous Cell Carcinoma

A

Usually central

MORE COMMON in smokers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe clinical features of small cell cancer and the poor prognostic features

A
  • MORE AGGRESSIVE than NSCLC
  • MORE SENSITIVE to chemo

Poor Px:

  • Extensive stage
  • Poor performance status
  • Hyponatraemia
  • Elevated ALP
  • Elevated LDH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Poor Prognosis Factors in NSCLC

A
  • reduced performance status
  • higher stage
  • weight loss >10% in large 6 months
  • presence of systemic symptoms
  • histology:
    large cell (LEAST FAVOURABLE), Adenocarcinoma (MOST FAVOURABLE)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Aside from hx of smoking (including passive) or exposure to indoor cooking fumes, what other risk factors for lung cancer?

A
Asbestos
Marijuana
Heavy metals
Radon
Radiation (esp breast and Hodgkins)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe bronchial carcinoid Tumour: who gets them, how do they present

A
  • Most common in CHILDREN and ADOLESCENTS
  • Present with Sx of endobronchial narrowing or obstruction
  • Carcinoid syndrome in 1-5%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Features of Carcinoid syndrome

A

Release vasoactive substances ie serotonin
–> flushing, bronchospasm, diarrhoea

Assoc with:

  • larger size
  • presence of liver mets
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe mesothelioma

A
  • Aggressive
  • Most significant RF is asbestos exposure
  • usually develop Sx from slowly enlarging pleural effusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How do you diagnose mesothelioma?

A

Either thoracentesis or closed pleural biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Where do pulmonary metastasis usually come from?

A

Carcinomas (colon, kidney, breast, testicle and thyroid)
Sarcoma
Melanoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Where do ENDOBRONCHIAL metastasis come from?

A

Usually renal cell carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What tumours spread with lymphangitic spread?

A

Adenocarcinomas (esp lung, breast and GIT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

If you see peripheral interstitial abnormality on HRCT which metastatic Cancers could you think of?

A

Melanoma
Lymphoma
Leukaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

DDx ANTERIOR mediastinal mass

A

1) Anterior mediastinal thymoma
2) lymphoma (usually younger, most commonly Hodgkins, then lymphoblastic then primary mediastinal diffuse large B Cell lymphoma)
3) teratoma

17
Q

Which paraneoplastic syndromes do you see in anterior mediastinal thymoma?

A

Usually in middle aged adults

  • myasthenia gravis
  • pure red blood cell aplasia
  • nonthymic cancers
  • acquired hypogammaglobulinaemia
18
Q

DDx middle mediastinal mass

A

Lymphadenopathy is most common

Cystic structures

19
Q

Where do NSCLC metastasise to?

A

Brain
Bone
Liver
Adrenal gland

20
Q

Which lung cancer do you NOT see finger clubbing in?

A

Small cell lung cancer

21
Q

Features of PANCOAST Tumour

A
  • superior sulcus tumours
  • usually NSCLC
  • pain in shoulder and neuropathic arm pain
  • Horner’s syndrome
  • wasted hand muscles (T1)
22
Q

Difference between PET and MRI in diagnosis

A

PET

  • does T well
  • good NPV for N but poor PPV
  • Very good for extrathoracic mets

MRI is superior for brain mets

23
Q

Small Cell Lung Ca STAGING

A

LIMITED: confined to ipsilateral hemithorax

EXTENSIVE: mets outside

24
Q

Small Cell Lung Ca TREATMENT

A

LIMITED:

  • curable in 20-30% with chemoradiotherapy
  • cisplatin and etoposide
  • prophylactic cranial irradiation

EXTENSIVE:
incurable
Palliative chemoradiotherapy

25
Staging of NSCLC
STAGE 1: T<5cm and N0 STAGE 2: T 5-9cm OR N1 (peribronchial or hilar LNs) STAGE 3: T <9cm OR invasion OR N2-3 (mediastinal or supraclavicular) STAGE 4: M1 including malignant effusion
26
Treatment of resectable STAGE 1, 2 & 3 lung NSCLC
STAGE 1: T<5cm and N0 STAGE 2: T 5-9cm OR N1 (peribronchial or hilar LNs) STAGE 3: T <9cm OR invasion OR N2-3 (mediastinal or supraclavicular) Surgery! - lobectomy preferred STAGE 2 ADD IN ADJUVANT CHEMO - cisplatin based (plus vinorelbine)
27
Why is LOBECTOMY preferred in Stage 1 and 2 NSCLC
WEDGE: higher rate local recurrence PNEUMECTOMY: higher risk complications and mortality, ESP RIGHT SIDED
28
Treatment of non-resectable Stage 2 or 3 Lung Ca
STAGE 2: T 5-9cm OR N1 (peribronchial or hilar LNs) STAGE 3: T <9cm OR invasion OR N2-3 (mediastinal or supraclavicular) Treat with CHEMORADIOTHERAPY If N2 disease and pancoast can give chemo as neoadjuvant and then try surgery
29
Treatment of Advanced NSCLC (stage 4)
Early referral to palliative care (Survival benefit) Look for targets for targeted therapy If no targetable mutations: First give double platinum chemo Then use pemetrexed if squamous cell
30
Contraindications to Lung Ca Surgery
- SVC obstruction - FEV <1.5 - MALIGNANT pleural effusion - Vocal cord paralysis - Tumour near hilum - Metastasis